Conexeu Sciences, Inc. (CNXU)
4.97
-0.30
(-5.69%)
USD |
NASDAQ |
Sep 04, 16:00
5.09
+0.12
(+2.41%)
After-Hours: 20:00
Conexeu Sciences Research and Development Expense (Quarterly) : 0.1523M for April 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 0.1523M |
| January 31, 2026 |
| Date | Value |
|---|---|
| October 31, 2025 | |
| April 30, 2025 | 0.0988M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AbbVie, Inc. | 2.344B |
| Vericel Corp. | 7.493M |
| ACADIA Pharmaceuticals, Inc. | 81.56M |
| Alnylam Pharmaceuticals, Inc. | 413.13M |
| Anika Therapeutics, Inc. | 7.341M |